157 related articles for article (PubMed ID: 30116910)
1. Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats.
Amor D; Goutal S; Marie S; Caillé F; Bauer M; Langer O; Auvity S; Tournier N
EJNMMI Res; 2018 Aug; 8(1):81. PubMed ID: 30116910
[TBL] [Abstract][Full Text] [Related]
2. [
Marie S; Breuil L; Chalampalakis Z; Becquemont L; Verstuyft C; Lecoq AL; Caillé F; Gervais P; Lebon V; Comtat C; Bottlaender M; Tournier N
Biomed Pharmacother; 2022 Dec; 156():113994. PubMed ID: 36411655
[TBL] [Abstract][Full Text] [Related]
3. Effect of Rifampicin on the Distribution of [
Bauer M; Traxl A; Matsuda A; Karch R; Philippe C; Nics L; Klebermass EM; Wulkersdorfer B; Weber M; Poschner S; Tournier N; Jäger W; Wadsak W; Hacker M; Wanek T; Zeitlinger M; Langer O
Mol Pharm; 2018 Oct; 15(10):4589-4598. PubMed ID: 30180590
[TBL] [Abstract][Full Text] [Related]
4. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.
Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y
Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of transporter-mediated hepatobiliary transport of newly developed
Kimura H; Yagi Y; Mikamo M; Maeda K; Kagawa S; Arimitsu K; Higashi T; Nishii R; Ono M; Nakamoto Y; Togashi K; Kusuhara H; Saji H
Drug Metab Pharmacokinet; 2019 Oct; 34(5):317-324. PubMed ID: 31331824
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of [
Yagi Y; Kimura H; Okuda H; Ono M; Nakamoto Y; Togashi K; Saji H
Nucl Med Biol; 2019; 74-75():25-31. PubMed ID: 31450072
[TBL] [Abstract][Full Text] [Related]
7. Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography.
Hernández Lozano I; Karch R; Bauer M; Blaickner M; Matsuda A; Wulkersdorfer B; Hacker M; Zeitlinger M; Langer O
AAPS J; 2019 Apr; 21(4):61. PubMed ID: 31037511
[TBL] [Abstract][Full Text] [Related]
8. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
[TBL] [Abstract][Full Text] [Related]
9. PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me.
Takashima T; Kitamura S; Wada Y; Tanaka M; Shigihara Y; Ishii H; Ijuin R; Shiomi S; Nakae T; Watanabe Y; Cui Y; Doi H; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
J Nucl Med; 2012 May; 53(5):741-8. PubMed ID: 22499612
[TBL] [Abstract][Full Text] [Related]
10. Imaging-Based Characterization of a
Marie S; Hernández-Lozano I; Breuil L; Truillet C; Hu S; Sparreboom A; Tournier N; Langer O
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34205780
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.
Shingaki T; Takashima T; Ijuin R; Zhang X; Onoue T; Katayama Y; Okauchi T; Hayashinaka E; Cui Y; Wada Y; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
J Pharmacol Exp Ther; 2013 Oct; 347(1):193-202. PubMed ID: 23926287
[TBL] [Abstract][Full Text] [Related]
12. Practical Synthesis of [
Nakaoka T; Uetake Y; Kaneko KI; Niwa T; Ochiai H; Irie S; Suezaki Y; Otsuka N; Hayashinaka E; Wada Y; Cui Y; Maeda K; Kusuhara H; Sugiyama Y; Hosoya T; Watanabe Y
Mol Pharm; 2020 Jun; 17(6):1884-1898. PubMed ID: 32271581
[TBL] [Abstract][Full Text] [Related]
13. A Clinical Quantitative Evaluation of Hepatobiliary Transport of [
Kaneko K; Tanaka M; Ishii A; Katayama Y; Nakaoka T; Irie S; Kawahata H; Yamanaga T; Wada Y; Miyake T; Toshimoto K; Maeda K; Cui Y; Enomoto M; Kawamura E; Kawada N; Kawabe J; Shiomi S; Kusuhara H; Sugiyama Y; Watanabe Y
Drug Metab Dispos; 2018 May; 46(5):719-728. PubMed ID: 29555827
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
Takeuchi K; Sugiura T; Umeda S; Matsubara K; Horikawa M; Nakamichi N; Silver DL; Ishiwata N; Kato Y
Drug Metab Dispos; 2011 Jun; 39(6):1088-96. PubMed ID: 21422191
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-Specific Deletion of EGFR in Mice Reduces Hepatic Abcg2 Transport Activity Measured by [
Traxl A; Komposch K; Glitzner E; Wanek T; Mairinger S; Langer O; Sibilia M
Drug Metab Dispos; 2017 Oct; 45(10):1093-1100. PubMed ID: 28790147
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Imaging Using
Marie S; Hernández-Lozano I; Le Vée M; Breuil L; Saba W; Goislard M; Goutal S; Truillet C; Langer O; Fardel O; Tournier N
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455390
[TBL] [Abstract][Full Text] [Related]
17. Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions.
Nishizawa K; Nakanishi T; Tamai I
Drug Metab Dispos; 2017 Feb; 45(2):224-227. PubMed ID: 27934638
[TBL] [Abstract][Full Text] [Related]
18. Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib.
Goutal S; Gerstenmayer M; Auvity S; Caillé F; Mériaux S; Buvat I; Larrat B; Tournier N
J Control Release; 2018 Dec; 292():210-220. PubMed ID: 30415015
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [
Traxl A; Mairinger S; Filip T; Sauberer M; Stanek J; Poschner S; Jäger W; Zoufal V; Novarino G; Tournier N; Bauer M; Wanek T; Langer O
Mol Pharm; 2019 Mar; 16(3):1282-1293. PubMed ID: 30694684
[TBL] [Abstract][Full Text] [Related]
20. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
